Article
UBS Maintains Buy on HCA Healthcare, Raises Price Target to $635
UBS analyst Andrew Mok maintains HCA Healthcare (NYSE:HCA) with a Buy and raises the price target from $598 to $635.
Comments
- No comments yet. Be the first to comment!